Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Expansion 2024-2033: Growth Drivers and Dynamics

The chronic obstructive pulmonary disease (copd) and asthma devices global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The chronic obstructive pulmonary disease (COPD) and asthma devices market size has grown strongly in recent years. It will grow from $42.49 billion in 2023 to $44.95 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to growth in the elderly population, increasing incidence of allergies, increasing government initiatives, rise in clinical research and trials, and rise in urbanization.

The chronic obstructive pulmonary disease (COPD) and asthma devices market size is expected to see strong growth in the next few years. It will grow to $57.08 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to rising occurrences of respiratory diseases, rising smoking of cigarettes, rising environmental pollution levels and breathing problems, growing prevalence of respiratory diseases, growing healthcare expenditure, and rising portability of drug delivery devices. Major trends in the forecast period include technological advancements, integration of smart technology, personalized medicine, adoption of biologics, and wearable respiratory monitors.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-and-asthma-devices-global-market-report

Scope Of Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview

Market Drivers –
The growing prevalence of respiratory diseases is expected to propel the growth of the chronic obstructive pulmonary disease (COPD) and asthma devices market going forward. Respiratory diseases encompass many conditions affecting the lungs and respiratory systems, such as asthma, chronic obstructive pulmonary disease, pneumonia, and lung cancer, impacting breathing and overall respiratory function. The growing prevalence of respiratory diseases is due to increasing air pollution levels, changing climate patterns affecting allergens and pathogens, and lifestyle habits such as smoking that compromise respiratory health. COPD and asthma devices play a crucial role in the comprehensive management and treatment of respiratory diseases, supporting patients to achieve better respiratory health and enhance their overall well-being. For instance, in March 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, chronic obstructive pulmonary disease (COPD) ranked as the third leading cause of death globally, resulting in approximately 3.23 million fatalities. Further, nearly 90% of these deaths in individuals under 70 years old occurred in low- and middle-income countries (LMICs). Therefore, the growing prevalence of respiratory diseases drives the growth of the chronic obstructive pulmonary disease (COPD) and asthma devices markets.

Market Trends –
Major companies operating in the chronic obstructive pulmonary disease (COPD) and asthma devices market are focusing on developing innovative technologies, such as inhalation devices, to integrate digital health features for remote monitoring and personalized treatment management. Inhalation devices are medical devices used to administer medications directly into the lungs through inhalation. For instance, in May 2022, Alkem Laboratories, an India-based pharmaceutical company, introduced the Innohaler, a dry powder inhaler (DPI) device, to make life easier for people with asthma and COPD. The Innohaler boasts advanced breath-actuated technology, ensuring precise medication delivery with each inhalation, optimizing dosage accuracy, and reducing waste. Its ergonomic design promotes ease of use, featuring a user-friendly interface that simplifies operation for patients of all ages. The device incorporates a compact and portable build, enhancing convenience for on-the-go use and improving patient adherence to prescribed treatments.

The chronic obstructive pulmonary disease (COPD) and asthma devices market covered in this report is segmented –

1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications
4) By End User: Pediatric, Adult, Geriatric

Get an inside scoop of the chronic obstructive pulmonary disease (copd) and asthma devices market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp

Regional Insights –
North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2023. The regions covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Major companies operating in the chronic obstructive pulmonary disease (COPD) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, 3M Health Care, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Baxter International Inc., Omron Corporation, Smiths Medical Inc., Recipharm AB, Cipla Ltd., Teleflex Incorporated, Chiesi Farmaceutici SpA, Lincre Holdings Inc., Sunovion Pharmaceuticals Inc., Verona Pharma plc, Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd.

Table of Contents
1. Executive Summary
2. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Report Structure
3. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Trends And Strategies
4. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market – Macro Economic Scenario
5. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Size and Growth
.
.
.
32. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Benchmarking
33. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
35. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model